Endosense SA – Trademark Portfolio
Entity Type: 03
Endosense SA holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 11 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TACTISYS. The owner is based in 1217 Meyrin.
Chemin du Grand-Puits 42
1217 Meyrin , CH
Showing of trademarks Trademarks
Trademark Classifications
Endosense SA's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Endosense SA have?
Endosense SA has 11 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 7 cancelled.
What trademark classes does Endosense SA file in?
Endosense SA files trademarks across 5 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 41 (Education & Entertainment). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Endosense SA's most well-known trademarks?
Endosense SA's registered trademark portfolio includes well-known marks such as TACTISYS. These are among 1 currently registered trademark in the portfolio.
What is Endosense SA's trademark registration success rate?
Endosense SA has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.